VEA
AVNS

Virtus ETF Advisers’s Avanos Medical AVNS Stock Holding History

Virtus ETF Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,830
Closed -$264K – 515
2026
Q1 		$264K Hold
18,830
– – 0.12% 188
2025
Q4 		$211K Buy
+18,830
New +$215K 0.1% 223

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Virtus ETF Advisers's AVNS Position: Q2 2026 in Review

Virtus ETF Advisers sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 18,830 shares — an estimated $264K sold.

Virtus ETF Advisers first reported a position in AVNS in Q4 2025 and held it in 2 quarters. The position peaked at $264K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Virtus ETF Advisers reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 18,830 Avanos Medical shares in Q2 2026, an estimated $264K.
  • Virtus ETF Advisers first reported a position in Avanos Medical in Q4 2025 and held it in 2 quarters.
  • Virtus ETF Advisers's Avanos Medical position peaked at $264K in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.